{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-044594","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.898589+00:00","generated_at":"2026-06-03T22:13:50.275056+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Clearside Biomedical appoints Anthony S. Gibney to its Board of Directors","bullets":["Mr. Gibney appointed as a Class III director effective April 15, 2024; term runs through 2025 annual meeting.","He brings over 25 years biotech experience including Iveric Bio, Achillion, and Leerink Partners.","Received an option to purchase 45,000 shares of CLSD common stock vesting over 36 months.","Entitled to $40,000 annual retainer plus additional annual option grants for continuous service."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-044594","json":"https://secwatch.observer/filing/0000950170-24-044594.json","markdown":"https://secwatch.observer/filing/0000950170-24-044594.md","text":"https://secwatch.observer/filing/0000950170-24-044594.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/0000950170-24-044594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/clsd-20240415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:13:50.275056+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"545dcb9bcd","claim":"Anthony S. Gibney was appointed as Director at Clearside Biomedical, Inc..","evidence_excerpt":"On April 15, 2024, the Board of Directors (the “ Board ”) of Clearside Biomedical, Inc. (the “ Company ”) appointed Anthony S. Gibney to serve as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/0000950170-24-044594-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}